Portal:AOP/FeaturedPathways

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Line 7: Line 7:
*[[Pathway:WP4017]] : Selective serotonin reuptake inhibitors lead to several adverse outcomes (Homo sapiens)
*[[Pathway:WP4017]] : Selective serotonin reuptake inhibitors lead to several adverse outcomes (Homo sapiens)
*[[Pathway:WP4026]] : Gastric ulcer formation (Homo sapiens)
*[[Pathway:WP4026]] : Gastric ulcer formation (Homo sapiens)
 +
*[[Pathway:WP2643]] : Nanoparticle-mediated activation of receptor signaling (Homo sapiens)
 +
*[[Pathway:WP2507]] : Nanomaterial induced apoptosis (Homo sapiens)
 +
*[[Pathway:WP2513]] : Nanoparticle triggered regulated necrosis (Homo sapiens)
 +
*[[Pathway:WP2509]] : Nanoparticle triggered autophagic cell death (Homo sapiens)
 +
*[[Pathway:WP3287]] : Overview of nanoparticle effects (Homo sapiens)
 +
*[[Pathway:WP3890]] : Nanomaterial induced inflammasome activation (Homo sapiens)
 +
*[[Pathway:WP3181]] : Nanoparticle-mediated activation of receptor signaling (Bos taurus)

Revision as of 11:21, 27 March 2018

Personal tools